
Albertsons Companies (ACI) Stock Forecast & Price Target
Albertsons Companies (ACI) Analyst Ratings
Bulls say
Albertsons Companies has demonstrated steady growth, with net sales revenue rising 2.08% year-over-year to $81.37 billion for the 12 months ending August 2025, driven by consistent demand across various channels, including grocery, pharmacy, and digital. The company reported a notable increase in pharmacy sales of 19% year-over-year, bolstered by rising prescription volumes and the demand for GLP-1 treatments, which helped mitigate the impact of food inflation. Additionally, digital sales surged by 21% in the third quarter of 2025, reflecting a strong e-commerce penetration of approximately 9.5% of total grocery sales, underscoring the potential for further growth as Albertsons optimizes its operations and enhances customer engagement.
Bears say
Albertsons Companies has experienced a notable decline in several key financial performance metrics, contributing to a negative outlook on its stock. The company's gross margin decreased to 27%, impacted by a shift towards lower-margin pharmacy and digital segments, alongside rising fulfillment costs. Furthermore, declines in Net Operating Profit After Tax (NOPAT), Economic Operating Cash Flow (EBITDAR), and Return on Capital (ROC) underscore ongoing profitability challenges amid significant strategic investments in technology and core initiatives.
This aggregate rating is based on analysts' research of Albertsons Companies and is not a guaranteed prediction by Public.com or investment advice.
Albertsons Companies (ACI) Analyst Forecast & Price Prediction
Start investing in Albertsons Companies (ACI)
Order type
Buy in
Order amount
Est. shares
0 shares